The Isotopes for Hope Podcast is a series that highlights Canadian leaders in the country's isotope and cancer care sector who are contributing to Canada's leadership role in fighting cancer. While this podcast aims to frame the industry’s future in this area, we also feature unique stories and perspectives about the importance of isotopes from current industry leaders. 

This episode features Dr. Rebecca Wong and Dr. Patrick Veit-Haibach of Toronto's University Health Network who share their perspectives on current and upcoming clinical trials using radiotheranostic drugs to improve patient outcomes. Radiotheranostics can both diagnose and treat cancers with far fewer side-effects from traditional treatments like chemotherapy or surgery, and offer promising results through personalized medicine. With Canada’s leading production sector and infrastructure, we have a significant opportunity to continue to lead in this space with strategic investments and policies across the supply chain.